A relação entre patentes farmacêuticas, doenças negligenciadas e o programa público brasileiro de produção e distribuição de medicamentos

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Reciclagem química por hidrólise da poliamida 6,6 reforçada com fibra de vidro após ciclos de reciclagem mecânica

Pós-graduação em Ciência e Tecnologia de Materiais - FC

Ciência e tecnologia X empreendorismo: dialogos possíveis e necessários

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Patentes patéticas

The objective of this project is to publish a book of scientific dissemination aimed at the subject of intellectual or industrial property, in particular patent, and its approval process. Based on a series of weekly blog posts published by its author, Patentes Patéticas use scientific, literary journalism and humour techniques to analyze a selection of U.S. patents that stand out for their questionable utility and criticize the number of patents granted as a metric of technological innovation in a country

Estudo da indústria farmacêutica brasileira: a queda das patentes e entrada dos medicamentos genéricos

The objective of this study is to examine the pharmaceutical industry and changes that the fall of patents and entry of generics may cause in the price and consumption of drugs. Thus, there is a brief discussion about the global pharmaceutical industry, from its origins to the present day, showing in particular the case of the United States, today considered the largest industry in this sector. From this, the work seeks to address specifically the Brazilian industry and its regulation. Since the generic law implementation, the participation of this type of medicine has grown significantly in the country. Because they have always been lower than prices of their brand, the cost of treating disease is reduced, which makes generic drugs represent an improvement for consumers in terms of welfare of society

Determinantes e indicadores de eco-inovação

This study aimed to gather the determinants and indicators of environmental innovations through a literature review on the topic. But before it was made a presentation of concepts and typology of eco-innovation, with different points of view. The determinant more found by most authors was regulation, followed by market factors, cost reductions and company image. To highlight these determinants were presented some cases studies, including evidence in Brazil. Due to the short bibliography and case studies, there are few indicators of environmental innovation found, highlighting the investment in environmental R&D and patents

Fatores associados com a regressão da hipertrofia esquerda em diálise e impacto com mortalidade cardiovascular

Pós-graduação em Fisiopatologia em Clínica Médica - FMB

Bioimperialismo e direito de propriedade intelectual: disputas pelo acesso ao cupuaçu e ao conhecimento tradicional

Pós-graduação em Ciências Sociais - FFC

Estratégias tecnológicas em transformação: um estudo da indústria farmacêutica brasileira

The aim of this research is to analyze the extension of changes in technological strategies of a group of Brazilian pharmaceutical companies, which we believe were induced by transformations in the institutional environment during the 1990s. Major institutional changes, such as the enacting of laws that recognized drug patents rights and fostered generic drugs market, have strengthened the market insertion and competitive position of these companies, what would enable an increase in research and development efforts in Brazil. In addition to the literature on technology strategy and drug industry, this study was based on interviews with six Brazilian pharmaceutical companies, all of which were ranked among the top national companies in the industry and have been considered in previous studies particularly active in the process of changing technological strategies. This research confirmed a significant intensification of technology efforts carried out by Brazilian drug companies. Nevertheless, the R&D intensity is still far below the global pattern and innovative impacts are slight.

Products for the treatment of inflammatory bowel disease: a patent review (2013-2014)

Introduction: Inflammatory bowel disease (IBD) consists of Crohn's disease, ulcerative colitis and an unspecific IBD. The unclear etiology of IBD is a limiting factor that complicates the development of new pharmacological treatments and explains the high frequency of refractory patients to current drugs, including both conventional and biological therapies. In view of this, recent progress on the development of novel patented products to treat IBD was reviewed.Areas covered: Evaluation of the patent literature during the period 2013 - 2014 focused on chemical compounds, functional foods and biological therapy useful for the treatment of IBD.Expert opinion: Majority of the patents are not conclusive because they were based on data from unspecific methods not related to intestinal inflammation and, when related to IBD models, few biochemical and molecular evaluations that could be corroborating their use in human IBD were presented. On the other hand, methods and strategies using new formulations of conventional drugs, guanylyl cyclase C peptide agonists, compounds that influence anti-adhesion molecules, mAbs anti-type I interferons and anti-integrin, oligonucleotide antisense Smad7, growth factor neuregulin 4 and functional foods, particularly fermented wheat germ with Saccharomyces cerevisiae, are promising products for use in the very near future.

Preliminary diagnosis of ophtalmological diseases through machine learning techniques

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Inovação e pesquisa em design nas universidades brasileiras

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Redes de inovação: mapeamento de inventores de patentes em uma empresa do setor de cosméticos

This article aims to identify patterns in the organization of innovation network by mapping the network inventors of a cosmetics company and identifying ways to promote innovation capacity through interconnectivity. The research was conducted through case study methods, and, for this, inventors mappings were made, based on the records of patents previously surveyed, taking into consideration the linkage (internal or external) of each inventor with the company and also the amount of patent citations. It was identified higher hierarchy in networks with the presence of collaborators externals to the company as well as a possible higher technological content, since the amount of citations was higher compared to other networks. It is verified, finally, that inventors mappings (although a patent is not the only measuring factor of innovation) can identify key features to help a better management of innovation.

As patentes de genes humanos sob a perspectiva do biodireito e da bioética

Pós-graduação em Direito - FCHS

Licenciamento provisório da patente: inibidores de protease no tratamento da Hepatite C crônica

Pós-graduação em Pesquisa e Desenvolvimento (Biotecnologia Médica) - FMB